Emerging evidence implicates palmitoylation in regulating nutrient transporters (e.g., GLUT1) and metabolic enzymes (e.g., ACLY), suggesting its potential role in rewiring glioma metabolism—a dimension meriting dedicated metabolomic studies. This evidence concerns the gene ACLY and central nervous system cancer.